AstraZeneca Testing Support Level: Stock Drops 9.59% (Agustus 4, 2026)
On Agustus 4, 2026: price 11,500.00 GBp, trend downtrend, RSI 41.7, support 12,364.00, resistance 14,364.00. technical analysis of astrazeneca stock.
Reuters-style market action on AstraZeneca’s London shares was emphatically negative on Thursday, with AZN.L last changing hands at 11,500.00 GBp, down from 12,720.00 at the previous close, according to Yahoo Finance data via the London Stock Exchange. The move leaves the stock 9.59% lower on the day and extends a 20.45% decline over one month, a pace that signals more than ordinary consolidation. It is the kind of slide that tells investors the market is still repricing the shares rather than merely pausing.
Trend & Price Action
The chart shows a stock that is still trading beneath the short- and medium-term trend markers, with price below SMA20 at 12,945.00 and also under SMA50 at 13,405.96. That matters because moving averages are not just lines on a chart: when price sits below both, it usually means rallies are being sold into before they can establish themselves as a new trend. The SMA20 slope of -2.61% over five days reinforces that weakness, showing the recent trend is still pointing down rather than flattening out.
There is no fresh MA-cross, which means the chart does not yet show a new technical turning point from the moving averages themselves. In plain language, the market has not produced the sort of crossover that would suggest the downtrend has been formally interrupted. Price is also sitting at -43% of the 20-day range, close to the lower end of its recent trading band, which usually reflects pressure rather than balance.
The broader range gives that reading more context. The shares are now below the 20-day Bollinger middle line at 12,945.00 and under the lower band at 11,767.37. That places the stock in a technically stretched zone on the downside, but stretched does not automatically mean reversed; it can also mean the market is still searching for a floor.
Oscillators & Momentum
Momentum is mixed, and that mix is important. The RSI at 41.7 is neutral, so it does not yet show a classic oversold condition that would normally accompany a sharp rebound. At the same time, the Stochastic %K at 83.7 and %D at 87.4 are overbought, which sounds contradictory until you read it as a timing signal: the stock may have been weak over the longer move, but the very short-term bounce has already run ahead of itself.
The MACD at -216.734 remains below zero, which keeps the broader momentum picture negative, but the histogram at 22.214 is positive and the MACD line is above its signal line at -238.948. That combination often means downward momentum is easing, even if it has not fully reversed. In other words, the selling pressure is still present, but the rate of decline is less aggressive than before. For traders reading the chart, that is usually a warning against assuming a straight-line continuation lower.
Volatility & Volume
Volatility is not extreme by band width alone, but it is still meaningful because the daily swing is large. The Bollinger band width of 18.2% is described as normal, which suggests the stock is not in a volatility squeeze that would typically precede a sudden breakout. Yet the ATR(14) at 643.37, equal to 5.6% of price, says the shares can still move sharply in a single session. That matters for interpretation: even without an unusual band compression, the stock is still capable of wide intraday ranges.
Volume is softer than usual. The latest print of 1,904,551 shares was only 0.7× the 20-day average of 2,928,409. Lower volume on a sharp drop can mean two different things: either the move is not yet fully validated by broad participation, or sellers are not needing heavy turnover to push the price lower. The OBV is rising, which is the one constructive volume signal in the set. OBV, or on-balance volume, tracks whether volume is accumulating on up days or down days; a rising reading while price weakens can hint that accumulation is quietly building beneath the surface.
Key Levels & Scenarios
The nearest technical map is clear. Support sits at 12,364.00 and resistance at 14,364.00, with the current price already below support. That is a weak structure, because former support that has been lost often becomes resistance on any bounce. The chart also shows the 3-month low at 9,892.00 and 3-month high at 15,126.00, which frame the wider range. With the stock trading much closer to the low than the high, the burden of proof remains on the bulls.
If price can reclaim 12,364.00 and then hold above the Bollinger middle band at 12,945.00, the chart would begin to look less damaged. If it fails to do that, the next test is whether the market can stabilize before revisiting the lower part of the 3-month range. The current setup says the rebound case needs confirmation, not assumption.
Technical Verdict: HOLD (wait & see)
HOLD (wait & see) is the cleanest technical call from this data set. The stock is in a downtrend and remains below SMA20 and SMA50, which keeps the broader structure weak. But the MACD histogram is positive and OBV is rising, so the market is not showing a clean, one-way bearish breakdown either. The Stochastic is overbought while price is still below key averages, which often argues for caution rather than immediacy.
- Ideal Entry Range: 12,364.00 to 12,945.00, where former support and the Bollinger middle band cluster.
- Exit Target: 14,122.63 to 14,364.00, using the upper Bollinger band and 20-day resistance as the first technical ceiling.
- Stop Loss protection: 11,767.37, the lower Bollinger band, because a break below it would confirm renewed downside pressure.
- Verdict invalidated if price breaks below 11,767.37 and fails to recover quickly.
For non-traders, this means the chart is still weak, but the indicators are not all pointing in the same direction yet. AstraZeneca’s London shares last traded at 11,500.00 GBp.
Summary Data AstraZeneca
| Last price | 11,500.00 GBp |
| Change 1 day / 5 days / 1 month | -9.59% / -9.23% / -20.45% |
| Trend / MA-cross | downtrend / none |
| SMA20 / SMA50 | 12,945.00 / 13,405.96 |
| RSI (14) / Stochastic %K | 41.7 / 83.7 |
| Bollinger %B / ATR | -11% / 643.37 |
| Support / Resistance 20 days | 12,364.00 / 14,364.00 |
| Data as of | 31 Juli 2026 14:00 WIB |
